Global Nasal Drug Delivery Technology Market

Dec 2018| VMR322A| Verified Market Research

Report Highlights

The global Nasal Drug Delivery Technology Market was valued at USD 43.89 billion in 2016 and is projected to reach USD 75.61 billion by 2025, growing at a CAGR of 6.23% from 2017 to 2025.

The nasal drug delivery market is increasing due to number of reason, increase in geriatric population and ease of self-administration and efficacy being some of them. The market is growing and expected to observe the same growth pattern all over the globe due to increase in demand and major lifestyle changes coupled with environmental factor (increasing air pollution and infections, air borne diseases).

Market Dynamics:
1. Market Drivers
1.1 Increasing demand of the drug delivery trough nasal cavity because of easy administration
1.2 Growing adoption of self-administration of medicines

2. Market Restraints
2.1 Risks associated with overuse of the medicine

Market Segmentation:
1. Global Nasal Drug Delivery Technology Market, by Containers:
1.1 Non-Pressurized Containers
1.2 Pressurized Containers

2. Global Nasal Drug Delivery Technology Market, by Dosage form:
2.1 Nasal Spray
2.2 Nasal Drops and Liquids
2.3 Nasal Gels
2.4 Nasal Powders
2.5 Others

3. Global Nasal Drug Delivery Technology Market, by Systems:
3.1 Multi Dose
3.2 Bi-Dose
3.3 Unit Dose

4. Global Nasal Drug Delivery Technology Market, by End User:
4.1 Hospitals
4.2 Home Health Care

5. Global Nasal Drug Delivery Technology Market, by Therapeutic Application:
5.1 Allergic and Non-Allergic Rhinitis
5.2 Nasal Congestion
5.3 Vaccinations
5.4 Other Applications

6. Global Nasal Drug Delivery Technology Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Merck & Co., Inc.
2. Novartis AG
3. Glaxosmithkline PLC
4. Johnson & Johnson Services, Inc.
5. Pfizer Inc.
6. Astrazeneca PLC
7. Aptargroup, Inc.
8. Aegis Therapeutics LLC
9. 3M
10. Becton, Dickinson and Company
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Nasal Drug Delivery Technology Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report